Paul Meyvisch

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Pulmonary Tuberculosis

Top Venues

Pharmaceutical statistics

Statistics in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Paul Meyvisch, Mitra Ebrahimpoor
On sample size calculation in drug interaction trials. Pharmaceutical statistics (2024)
Paul Meyvisch, Mitra Ebrahimpoor
On sample size calculation in drug interaction trials. Pharmaceutical statistics 23 (4) (2024)
Wim Van der Elst, Ariel Alonso Abad, Hans Coppenolle, Paul Meyvisch, Geert Molenberghs
The individual-level surrogate threshold effect in a causal-inference setting with normally distributed endpoints. Pharmaceutical statistics 20 (6) (2021)
Paul Meyvisch, Ariel Alonso, Wim Van der Elst, Geert Molenberghs
On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomes. Statistics in medicine 39 (26) (2020)
Paul Meyvisch, Chrispin Kambili, Koen Andries, Nacer Lounis, Myriam Theeuwes, Brian Dannemann, An Vandebosch, Wim Van der Elst, Geert Molenberghs, Ariel Alonso
Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial. PloS one 13 (7) (2018)
Paul Meyvisch, Ariel Alonso, Wim Van der Elst, Geert Molenberghs
Assessing the predictive value of a binary surrogate for a binary true endpoint based on the minimum probability of a prediction error. Pharmaceutical statistics 18 (3) (2018)